Hologic, Inc. (HOLX)
USD 71.47
(-1.09%)
USD 71.47
(-1.09%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 882.6 Million USD | 32.05% |
| 2023 | 668.4 Million USD | -59.25% |
| 2022 | 1.64 Billion USD | -33.87% |
| 2021 | 2.48 Billion USD | 124.46% |
| 2020 | 1.1 Billion USD | 722.17% |
| 2019 | 134.4 Million USD | 156.49% |
| 2018 | -237.9 Million USD | -117.36% |
| 2017 | 1.37 Billion USD | 149.76% |
| 2016 | 548.6 Million USD | 20.54% |
| 2015 | 455.1 Million USD | 62.71% |
| 2014 | 279.7 Million USD | 130.86% |
| 2013 | -906.28 Million USD | -896.96% |
| 2012 | 113.71 Million USD | -69.63% |
| 2011 | 374.44 Million USD | 435.4% |
| 2010 | 69.93 Million USD | 103.47% |
| 2009 | -2.01 Billion USD | -920.88% |
| 2008 | -197.54 Million USD | -233.7% |
| 2007 | 147.75 Million USD | 193.51% |
| 2006 | 50.33 Million USD | 54.27% |
| 2005 | 32.63 Million USD | 159.26% |
| 2004 | 12.58 Million USD | 316.07% |
| 2003 | 3.02 Million USD | 40.24% |
| 2002 | 2.15 Million USD | 111.47% |
| 2001 | -18.8 Million USD | 31.26% |
| 2000 | -27.35 Million USD | -184.99% |
| 1999 | -9.6 Million USD | -188.89% |
| 1998 | 10.8 Million USD | -51.79% |
| 1997 | 22.4 Million USD | 85.12% |
| 1996 | 12.1 Million USD | 157.45% |
| 1995 | 4.7 Million USD | 14.63% |
| 1994 | 4.1 Million USD | 305.0% |
| 1993 | -2 Million USD | -253.85% |
| 1992 | 1.3 Million USD | 550.0% |
| 1991 | 200 Thousand USD | -93.75% |
| 1990 | 3.2 Million USD | 88.24% |
| 1989 | 1.7 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | 230.1 Million USD | -12.81% |
| 2024 Q2 | 243.3 Million USD | 22.75% |
| 2024 Q3 | 263.89 Million USD | 8.47% |
| 2024 Q1 | 198.2 Million USD | 49.58% |
| 2023 Q2 | 272.1 Million USD | 3.7% |
| 2023 Q4 | 132.5 Million USD | 9364.29% |
| 2023 Q3 | 1.4 Million USD | -99.49% |
| 2023 FY | 668.4 Million USD | -59.25% |
| 2023 Q1 | 262.4 Million USD | 86.23% |
| 2022 Q4 | 140.9 Million USD | -46.61% |
| 2022 Q3 | 263.9 Million USD | -55.58% |
| 2022 Q1 | 641.3 Million USD | 45.92% |
| 2022 FY | 1.64 Billion USD | -33.87% |
| 2022 Q2 | 594.1 Million USD | -7.36% |
| 2021 FY | 2.48 Billion USD | 124.46% |
| 2021 Q1 | 885.5 Million USD | 39.93% |
| 2021 Q2 | 796.8 Million USD | -10.02% |
| 2021 Q3 | 358.6 Million USD | -54.99% |
| 2021 Q4 | 439.5 Million USD | 22.56% |
| 2020 Q4 | 632.8 Million USD | 231.31% |
| 2020 Q3 | 191 Million USD | 22.12% |
| 2020 Q2 | 156.4 Million USD | 25.32% |
| 2020 FY | 1.1 Billion USD | 722.17% |
| 2020 Q1 | 124.8 Million USD | 64.21% |
| 2019 FY | 134.4 Million USD | 156.49% |
| 2019 Q1 | 140.5 Million USD | 41.63% |
| 2019 Q2 | -323.2 Million USD | -330.04% |
| 2019 Q3 | 145.3 Million USD | 144.96% |
| 2019 Q4 | 76 Million USD | -47.69% |
| 2018 Q3 | 133.1 Million USD | 122.03% |
| 2018 Q2 | -604.2 Million USD | -550.56% |
| 2018 Q1 | 134.1 Million USD | 22.58% |
| 2018 FY | -237.9 Million USD | -117.36% |
| 2018 Q4 | 99.2 Million USD | -25.47% |
| 2017 Q2 | 999.8 Million USD | 584.79% |
| 2017 Q3 | 115 Million USD | -88.5% |
| 2017 Q4 | 109.4 Million USD | -4.87% |
| 2017 Q1 | 146 Million USD | -0.75% |
| 2017 FY | 1.37 Billion USD | 149.76% |
| 2016 Q4 | 147.1 Million USD | 5.52% |
| 2016 Q1 | 126.1 Million USD | 0.32% |
| 2016 FY | 548.6 Million USD | 20.54% |
| 2016 Q3 | 139.4 Million USD | 2.42% |
| 2016 Q2 | 136.1 Million USD | 7.93% |
| 2015 Q3 | 116 Million USD | 5.65% |
| 2015 Q2 | 109.8 Million USD | 6.09% |
| 2015 Q1 | 103.5 Million USD | 12.62% |
| 2015 FY | 455.1 Million USD | 62.71% |
| 2015 Q4 | 125.7 Million USD | 8.36% |
| 2014 Q3 | 76.2 Million USD | 51.64% |
| 2014 Q4 | 91.9 Million USD | 20.6% |
| 2014 FY | 279.7 Million USD | 130.86% |
| 2014 Q1 | 61.28 Million USD | 105.91% |
| 2014 Q2 | 50.25 Million USD | -18.01% |
| 2013 FY | -906.28 Million USD | -896.96% |
| 2013 Q4 | -1.03 Billion USD | -1794.47% |
| 2013 Q3 | 61.15 Million USD | 1003.43% |
| 2013 Q2 | 5.54 Million USD | -91.24% |
| 2013 Q1 | 63.22 Million USD | 244.68% |
| 2012 FY | 113.71 Million USD | -69.63% |
| 2012 Q1 | 66.75 Million USD | -9.07% |
| 2012 Q3 | 80.52 Million USD | 694.62% |
| 2012 Q4 | -43.7 Million USD | -154.27% |
| 2012 Q2 | 10.13 Million USD | -84.82% |
| 2011 Q3 | 73.91 Million USD | -52.43% |
| 2011 Q1 | 71.72 Million USD | 150.26% |
| 2011 Q2 | 155.38 Million USD | 116.66% |
| 2011 FY | 374.44 Million USD | 435.4% |
| 2011 Q4 | 73.42 Million USD | -0.67% |
| 2010 Q2 | 61.9 Million USD | -13.99% |
| 2010 FY | 69.93 Million USD | 103.47% |
| 2010 Q3 | 78.77 Million USD | 27.26% |
| 2010 Q4 | -142.7 Million USD | -281.16% |
| 2010 Q1 | 71.96 Million USD | -4.94% |
| 2009 Q2 | -2.26 Billion USD | -2516.59% |
| 2009 Q1 | 93.72 Million USD | 205.91% |
| 2009 Q3 | 78.74 Million USD | 103.48% |
| 2009 Q4 | 75.71 Million USD | -3.85% |
| 2009 FY | -2.01 Billion USD | -920.88% |
| 2008 Q2 | 106.11 Million USD | 132.87% |
| 2008 Q4 | -88.49 Million USD | -182.22% |
| 2008 Q3 | 107.62 Million USD | 1.42% |
| 2008 Q1 | -322.78 Million USD | -794.18% |
| 2008 FY | -197.54 Million USD | -233.7% |
| 2007 FY | 147.75 Million USD | 193.51% |
| 2007 Q1 | 26.51 Million USD | 250.75% |
| 2007 Q2 | 34.8 Million USD | 31.25% |
| 2007 Q3 | 39.93 Million USD | 14.73% |
| 2007 Q4 | 46.49 Million USD | 16.44% |
| 2006 Q1 | 7.8 Million USD | -31.58% |
| 2006 Q4 | 7.56 Million USD | -59.31% |
| 2006 Q3 | 18.58 Million USD | 13.35% |
| 2006 Q2 | 16.39 Million USD | 109.99% |
| 2006 FY | 50.33 Million USD | 54.27% |
| 2005 Q2 | 7.18 Million USD | 56.45% |
| 2005 Q3 | 9.45 Million USD | 31.61% |
| 2005 Q4 | 11.4 Million USD | 20.72% |
| 2005 FY | 32.63 Million USD | 159.26% |
| 2005 Q1 | 4.59 Million USD | -12.6% |
| 2004 Q3 | 3.42 Million USD | 20.41% |
| 2004 Q2 | 2.84 Million USD | 168.24% |
| 2004 Q4 | 5.25 Million USD | 53.25% |
| 2004 Q1 | 1.06 Million USD | -59.99% |
| 2004 FY | 12.58 Million USD | 316.07% |
| 2003 FY | 3.02 Million USD | 40.24% |
| 2003 Q4 | 2.65 Million USD | 143.08% |
| 2003 Q2 | 343 Thousand USD | 132.33% |
| 2003 Q3 | 1.09 Million USD | 218.08% |
| 2003 Q1 | -1.06 Million USD | -184.27% |
| 2002 Q4 | 1.25 Million USD | 21.41% |
| 2002 Q2 | 643 Thousand USD | 182.33% |
| 2002 Q1 | -781 Thousand USD | 81.64% |
| 2002 FY | 2.15 Million USD | 111.47% |
| 2002 Q3 | 1.03 Million USD | 61.28% |
| 2001 Q3 | -466 Thousand USD | 93.46% |
| 2001 Q4 | -4.25 Million USD | -812.66% |
| 2001 FY | -18.8 Million USD | 31.26% |
| 2001 Q2 | -7.12 Million USD | -0.95% |
| 2001 Q1 | -7.06 Million USD | 44.31% |
| 2000 Q1 | -5.2 Million USD | 14.75% |
| 2000 FY | -27.35 Million USD | -184.99% |
| 2000 Q2 | -4.36 Million USD | 16.04% |
| 2000 Q3 | -5.02 Million USD | -15.05% |
| 2000 Q4 | -12.67 Million USD | -152.38% |
| 1999 Q2 | -2.9 Million USD | -363.64% |
| 1999 FY | -9.6 Million USD | -188.89% |
| 1999 Q1 | 1.1 Million USD | -65.63% |
| 1999 Q4 | -6.1 Million USD | -96.77% |
| 1999 Q3 | -3.1 Million USD | -6.9% |
| 1998 FY | 10.8 Million USD | -51.79% |
| 1998 Q2 | 2.9 Million USD | 45.0% |
| 1998 Q3 | 4.5 Million USD | 55.17% |
| 1998 Q4 | 3.2 Million USD | -28.89% |
| 1998 Q1 | 2 Million USD | -53.49% |
| 1997 Q2 | 6.1 Million USD | 3.39% |
| 1997 Q4 | 4.3 Million USD | -29.51% |
| 1997 Q3 | 6.1 Million USD | 0.0% |
| 1997 FY | 22.4 Million USD | 85.12% |
| 1997 Q1 | 5.9 Million USD | 1866.67% |
| 1996 Q2 | 3.8 Million USD | 46.15% |
| 1996 Q4 | 300 Thousand USD | -94.64% |
| 1996 Q3 | 5.6 Million USD | 47.37% |
| 1996 Q1 | 2.6 Million USD | 30.0% |
| 1996 FY | 12.1 Million USD | 157.45% |
| 1995 Q2 | 100 Thousand USD | -90.0% |
| 1995 Q3 | 1.3 Million USD | 1200.0% |
| 1995 Q1 | 1 Million USD | 42.86% |
| 1995 Q4 | 2 Million USD | 53.85% |
| 1995 FY | 4.7 Million USD | 14.63% |
| 1994 Q2 | 1.4 Million USD | 180.0% |
| 1994 Q1 | 500 Thousand USD | 145.45% |
| 1994 FY | 4.1 Million USD | 305.0% |
| 1994 Q4 | 700 Thousand USD | -53.33% |
| 1994 Q3 | 1.5 Million USD | 7.14% |
| 1993 Q2 | -300 Thousand USD | -105.56% |
| 1993 FY | -2 Million USD | -253.85% |
| 1993 Q4 | -1.1 Million USD | -450.0% |
| 1993 Q1 | 5.4 Million USD | 2800.0% |
| 1993 Q3 | -200 Thousand USD | 33.33% |
| 1992 FY | 1.3 Million USD | 550.0% |
| 1992 Q4 | -200 Thousand USD | -133.33% |
| 1992 Q1 | 200 Thousand USD | 101.61% |
| 1992 Q2 | 500 Thousand USD | 150.0% |
| 1992 Q3 | 600 Thousand USD | 20.0% |
| 1991 Q1 | 3.9 Million USD | 133.05% |
| 1991 Q2 | 4.2 Million USD | 7.69% |
| 1991 Q3 | 4.5 Million USD | 7.14% |
| 1991 Q4 | -12.4 Million USD | -375.56% |
| 1991 FY | 200 Thousand USD | -93.75% |
| 1990 FY | 3.2 Million USD | 88.24% |
| 1990 Q1 | 3.9 Million USD | 161.9% |
| 1990 Q4 | -11.8 Million USD | -296.67% |
| 1990 Q3 | 6 Million USD | 650.0% |
| 1990 Q2 | 800 Thousand USD | -79.49% |
| 1989 Q2 | 2.6 Million USD | 18.18% |
| 1989 Q3 | 3.2 Million USD | 23.08% |
| 1989 Q4 | -6.3 Million USD | -296.88% |
| 1989 FY | 1.7 Million USD | 0.0% |
| 1989 Q1 | 2.2 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 1630.485% |
| AngioDynamics, Inc. | -97.71 Million USD | 1003.211% |
| AtriCure, Inc. | -26.68 Million USD | 3407.724% |
| Avinger, Inc. | -16.63 Million USD | 5405.681% |
| Azenta, Inc. | -73.12 Million USD | 1306.958% |
| BioLife Solutions, Inc. | -70.82 Million USD | 1346.17% |
| The Cooper Companies, Inc. | 533.1 Million USD | -65.56% |
| Daxor Corporation | -177.07 Thousand USD | 498532.867% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 5940.392% |
| Femasys Inc. | -14.5 Million USD | 6183.366% |
| GlucoTrack, Inc. | -7.1 Million USD | 12523.986% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -46499.789% |
| ICU Medical, Inc. | 22.82 Million USD | -3766.813% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 50.045% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 8693.981% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | -2280.131% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 12890.3% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 12890.3% |
| Masimo Corporation | 136.5 Million USD | -546.593% |
| Microbot Medical Inc. | -9.85 Million USD | 9055.86% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | -5914.335% |
| Merit Medical Systems, Inc. | 123.94 Million USD | -612.096% |
| Nephros, Inc. | -1.59 Million USD | 55504.896% |
| NovoCure Limited | -232.87 Million USD | 479.01% |
| NEXGEL, Inc. | -3.47 Million USD | 25483.952% |
| NEXGEL, Inc. | -3.47 Million USD | 25483.952% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 958.552% |
| OraSure Technologies, Inc. | 54.07 Million USD | -1532.057% |
| Pro-Dex, Inc. | 7.17 Million USD | -12204.475% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 2125.52% |
| Predictive Oncology Inc. | -13.92 Million USD | 6439.912% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 32496.921% |
| QuidelOrtho Corporation | 139.1 Million USD | -534.508% |
| Repligen Corporation | 54.57 Million USD | -1517.194% |
| Sanara MedTech Inc. | -4.21 Million USD | 21038.742% |
| STAAR Surgical Company | 28.09 Million USD | -3041.261% |
| Sharps Technology, Inc. | -10.12 Million USD | 8815.617% |
| Utah Medical Products, Inc. | 16.77 Million USD | -5160.774% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 1138.353% |
| Jin Medical International Ltd. | 2.86 Million USD | -30681.979% |